Brompheniramine
- TRADE NAMES: Bromfed (Muro); Bromine; Brommine; Bromphen; Dimegan; Dimetane; Ilvin; Kinmedon; Nasahist; ND-Stat; Neo-Meton; Rondec (Biovail)
- INDICATIONS: Allergic rhinitis, urticaria
- CLASS: Histamine H1 receptor antagonist
- HALF-LIFE: 12–48 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Aprobarbital, Butabarbital, Chloral Hydrate, Ethchlorvynol, Mephobarbital, Pentobarbital, Phenobarbital, Phenothiazines, Primidone, Secobarbital, Zolpidem
PREGNANCY CATEGORY: C
Please login to see the rest of this drug profile
SKIN.
MUCOSAL.
CENTRAL NERVOUS SYSTEM.
NEUROMUSCULAR/SKELETAL.
OTHER.
Page last updated 08/01/2022
Symbol key
Incidence 
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Seriousness
- Hospitalization possible
- Life threatening
- Fatal
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric
